Immunocore Holdings Stock Forecast

Stock Price Forecast

According to 11 analysts polled by S&P Global, Immunocore Holdings stock has a consensus rating of "Strong Buy" and an average price target of $62.73. The average 1-year stock price forecast is 113.80% higher than the current stock price, while the lowest is $34 (+15.88%) and the highest is $100 (+240.83%).

Price Target: $62.73 (+113.80%)

Analyst Consensus: Strong Buy

Price Target

Chart

Target	Low	Average	Median	High
Price	$34	$62.73	$60	$100
Change	+15.88%	+113.80%	+104.50%	+240.83%

Analyst Ratings

The average analyst rating for Immunocore Holdings stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Chart

Rating	Mar '26	Apr '26	May '26	Jun '26	Jul '26	Aug '26
Strong Buy	10	10	10	9	8	2
Buy	1	1	1	1	1	1
Hold	4	4	4	4	4	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	15	15	15	14	13	3

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Patrick Trucchio H.C. Wainwright	H.C. Wainwright	Buy Maintains $100	Buy	Maintains	$100	+240.83%	Sep 22, 2026
Jessica Fye J.P. Morgan	J.P. Morgan	Buy Initiates $50	Buy	Initiates	$50	+70.42%	Aug 21, 2026
Sean Laaman Morgan Stanley	Morgan Stanley	Hold Maintains $40 → $43	Hold	Maintains	$40 → $43	+46.56%	Aug 7, 2026
Rajan Sharma Goldman Sachs	Goldman Sachs	Buy Maintains $73 → $74	Buy	Maintains	$73 → $74	+152.22%	Aug 7, 2026
Graig Suvannavejh Mizuho Securities	Mizuho Securities	Hold Maintains $35	Hold	Maintains	$35	+19.29%	Aug 7, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

452.25M

from 400.02M

13.06%

from 400.02M

Revenue Next Year

488.96M

from 452.25M

8.12%

from 452.25M

EPS This Year

-0.07

from -0.71

EPS Next Year

-0.75

from -0.07

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	36.48M	174.36M	249.43M	310.20M	400.02M	452.25M
Revenue Growth	-11.26%	377.91%	43.05%	24.37%	28.95%	13.06%
Operating Income	-174.66M	-51.70M	-60.55M	-52.41M	-25.63M	-16.13M
Net Income	-180.03M	-52.54M	-55.29M	-51.09M	-35.51M	-1.04M
EPS	-	-	-	-	-0.71	-0.07
Free Cash Flow	-	-	-	-	-15.05M	-55.80M
No. Analysts	-	-	-	-	-	13

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Chart

Revenue	2026	2027	2028
High	468.1M
Avg	452.3M
Low	440.5M

Revenue Growth

Chart

Revenue Growth	2026	2027	2028
High	17.0%
Avg	13.1%
Low	10.1%

EPS Forecast

Chart

EPS	2026	2027	2028
High	0.29
Avg	-0.07
Low	-0.58

EPS Growth

Chart

EPS Growth	2026	2027	2028
High	-
Avg	-
Low	-